Drug Approval | February 25, 2023
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services
Completion of the demerger of Haleon and share consolidation of GSK
The company was directed to submit a plan of compliance by July 15, 2022
The proposed demerger is the most significant corporate change for GSK in the last 20 years
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
The approval by the DCGI comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO)
Subscribe To Our Newsletter & Stay Updated
